SISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend

Bulletin Express

03/06

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復銳醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.

According to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1129289640"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129289640\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129289640?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 17:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129289640","market":"us","top_or_hot":-1,"title":"SISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend","media":"Bulletin Express","content":"<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復銳醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.</p>\n<p>According to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSISRAM MED (01696) Schedules Board Meeting for 2025 Annual Results and Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-06 17:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復銳醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.</p>\n<p>According to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01696","symbol_name":"復鋭醫療科技","start_time":0,"source_url":"","article_id":"1129289640","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129289640","pubTimestamp":1772789065,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01696":"复锐医疗科技"},"translate_title":"SISRAM MED(01696)安排董事会会议讨论2025年年度业绩和股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01696":1},"content_text":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim any liability for the contents of the announcement and make no representation as to its accuracy or completeness. Sisram Medical Ltd (復鋭醫療科技有限公司*) has announced that its board of directors will convene on Monday, 23 March 2026 to review and approve the Group’s annual results for the year ended 31 December 2025, consider recommending a final dividend (if any), and address other relevant matters.\nAccording to the announcement dated 6 March 2026, the Board of Sisram Medical Ltd consists of Executive Directors Mr. Lior Moshe DAYAN (Chairman) and Mr. Jiahong LI; Non-Executive Directors Mr. Yi LIU, Ms. Rongli FENG, and Ms. Caroline Xiaokui JIN; as well as Independent Non-Executive Directors Mr. Heung Sang Addy FONG, Mr. Chi Fung Leo CHAN, Ms. Jenny CHEN, and Mr. Kai Yu Kenneth LIU.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}